News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY)'s Profit Tops Estimates on Sales Growth


10/23/2013 7:10:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Bristol-Myers Squibb Co. (BMY) beat analysts’ third-quarter earnings and sales estimates as demand for the company’s cancer and arthritis drugs grew. Profit excluding certain items was 46 cents a share, beating the average 44 cents of 16 analysts’ estimates compiled by Bloomberg. Sales increased 9 percent to $4.07 billion, the New York-based drugmaker said in a statement.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com
Read at Reuters
Read at Fox News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES